Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$16.40
1.7411.87%
At close: Dec 4, 4:00 PM EST
$16.29
-0.11-0.67%
After Hours: 5:30 PM EST
Comments
Loading...
KalVista Pharmaceuticals (KALV) Stock Price, Quote, News & History
KALVNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy KalVista Pharmaceuticals (KALV) stock?
You can purchase shares of KalVista Pharmaceuticals (NASDAQ:KALV) through any online brokerage.
Who are KalVista Pharmaceuticals (KALV) competitors?
Other companies in KalVista Pharmaceuticals’s space includes: CytomX Therapeutics Inc (NASDAQ:CTMX), Gyre Therapeutics Inc (NASDAQ:GYRE), Valneva SE (NASDAQ:VALN), Replimune Group Inc (NASDAQ:REPL) and Day One Biopharmaceuticals Inc (NASDAQ:DAWN).
What is the forecast, or price target, for KalVista Pharmaceuticals (KALV) stock?
KalVista Pharmaceuticals has a consensus price target of $25.20.
What is the current price for KalVista Pharmaceuticals (KALV)?
The stock price for KalVista Pharmaceuticals (NASDAQ: KALV) is $16.29 last updated December 4, 2025 at 5:30 PM EST.
Does KalVista Pharmaceuticals (KALV) pay a dividend?
There are no upcoming dividends for KalVista Pharmaceuticals.
When is KalVista Pharmaceuticals (NASDAQ:KALV) reporting earnings?
KalVista Pharmaceuticals does not have any upcoming earnings scheduled.
Is KalVista Pharmaceuticals (KALV) going to split?
There is no upcoming split for KalVista Pharmaceuticals.
What sector and industry does KalVista Pharmaceuticals (KALV) operate in?
KalVista Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
